SCHEMBL1936880

SCHEMBL1936880

Cc1ccc(C(=O)NC2(c3ccccc3)CC2)cc1-c1ccn2nc(-c3ccc(F)cc3)c(C(=O)NS(C)(=O)=O)c2c1F

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C8 P10632 6/20 0.48
CYP3A4 P08684 5/20 0.48
KCNH2 Q12809 3/20 0.43
DHODH Q02127 1/20 0.40
NR1I2 O75469 1/20 0.39
MAPK14 Q16539 2/20 0.37
TTK P33981 1/20 0.35
IDO1 P14902 4/20 0.35
DGAT2 Q96PD7 1/20 0.35
TACR3 P29371 1/20 0.34
ROCK2 O75116 1/20 0.33
ROCK1 Q13464 1/20 0.33
SCN2B O60939 1/20 0.33
SCN1A P35498 1/20 0.33
SCN1B Q07699 1/20 0.33
SCN5A Q14524 1/20 0.33
SCN9A Q15858 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1937117 0.91 CYP2C8 (0.57) CYP2C8CYP3A4KCNH2NR1I2MAPK14
SCHEMBL1937067 0.81 CYP2C8 (0.48) CYP2C8CYP3A4KCNH2NR1I2MAPK14
SCHEMBL2464715 0.81 CYP2C8 (0.65) CYP2C8CYP3A4KCNH2NR1I2MAPK14
SCHEMBL1936127 0.81 CYP2C8 (0.61) CYP2C8CYP3A4KCNH2NR1I2MAPK14
SCHEMBL2997319 0.79 CYP2C8 (0.42) CYP2C8CYP3A4KCNH2DHODHNR1I2
SCHEMBL9911913 0.79 CYP2C8 (0.46) CYP2C8CYP3A4KCNH2NR1I2MAPK14
SCHEMBL9911912 0.78 CYP2C8 (0.49) CYP2C8CYP3A4KCNH2NR1I2MAPK14
SCHEMBL9911902 0.78 CYP2C8 (0.62) CYP2C8CYP3A4KCNH2NR1I2MAPK14
SCHEMBL2465993 0.76 CYP2C8 (0.41) CYP2C8CYP3A4KCNH2NR1I2TACR3
SCHEMBL667380 0.76 CYP2C8 (0.59) CYP2C8CYP3A4KCNH2NR1I2MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2331502-A2 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Bristol-Myers Squibb Company (US) 2011-06-15 EP disclosed
WO-2010030538-A2 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2010-03-18 WO disclosed